The company is also starting Phase III trials of its recombinant protein vaccine candidate from August.from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccines-|-biological-e-to-begin-producing-75-80-million-dosesvaccine-candidateaugust-2021_15067361.html
No comments:
Post a Comment